Diagnos Stock Today
| ADK Stock | CAD 0.28 0.01 3.70% |
Performance0 of 100
| Odds Of DistressOver 65
|
Diagnos is selling for under 0.28 as of the 30th of November 2024; that is 3.70 percent increase since the beginning of the trading day. The stock's lowest day price was 0.28. Diagnos has more than 65 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Diagnos are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of June 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
DIAGNOS Inc. provides software-based interpretation services in Canada, the United States, Kenya, the United Arab Emirates, Saudi Arabia, Mexico, and internationally. The company was founded in 1998 and is headquartered in Brossard, Canada. DIAGNOS INC operates under Health Information Services classification in Canada and is traded on TSX Venture Exchange.. The company has 95 M outstanding shares of which 66.56 K shares are presently shorted by private and institutional investors with about 0.06 days to cover all short positions. More on Diagnos
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Diagnos Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Diagnos' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Diagnos or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Andre Larente | ||||
| Business Concentration | Health Care Technology, Health Care Equipment & Services, Health Care, Health Care, Health Care Technology, Health Information Services, Technology (View all Sectors) | ||||
Diagnos' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Diagnos' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsDiagnos can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Diagnos' financial leverage. It provides some insight into what part of Diagnos' total assets is financed by creditors.
| |||||
Diagnos (ADK) is traded on TSX Venture Exchange in Canada and employs 5 people. Diagnos is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 27.07 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Diagnos's market, we take the total number of its shares issued and multiply it by Diagnos's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Diagnos classifies itself under Health Care Technology sector and is part of Health Care industry. The entity has 95 M outstanding shares of which 66.56 K shares are presently shorted by private and institutional investors with about 0.06 days to cover all short positions.
Diagnos has accumulated about 97.5 K in cash with (2.41 M) of positive cash flow from operations.
Check Diagnos Probability Of Bankruptcy
Ownership AllocationDiagnos holds a total of 95 Million outstanding shares. Diagnos shows 14.41 percent of its outstanding shares held by insiders and 0.01 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Diagnos Ownership Details
Diagnos Risk Profiles
Although Diagnos' alpha and beta are two of the key measurements used to evaluate Diagnos' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.12 | |||
| Standard Deviation | 2.91 | |||
| Variance | 8.47 | |||
| Risk Adjusted Performance | (0.10) |
Diagnos Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Diagnos without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Diagnos Corporate Executives
Elected by the shareholders, the Diagnos' board of directors comprises two types of representatives: Diagnos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Diagnos. The board's role is to monitor Diagnos' management team and ensure that shareholders' interests are well served. Diagnos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Diagnos' outside directors are responsible for providing unbiased perspectives on the board's policies.
| MarcAndr Massue | CFO Finance | Profile |
Additional Tools for Diagnos Stock Analysis
When running Diagnos' price analysis, check to measure Diagnos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnos is operating at the current time. Most of Diagnos' value examination focuses on studying past and present price action to predict the probability of Diagnos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnos' price. Additionally, you may evaluate how the addition of Diagnos to your portfolios can decrease your overall portfolio volatility.